Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
06 Noviembre 2023 - 3:05PM
Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering
drug-eluting biomatrix products, today announced that it will
release its third quarter 2023 financial results after market close
on Monday, November 13, 2023. Members of the Company’s management
team will host a conference call and webcast starting at 4:30 p.m.
Eastern Time / 1:30 p.m. Pacific Time on the same day.
The conference call can be accessed using the
following information:
Webcast: Click hereU.S.
Investors: 877-407-8029International
Investors: 201-689-8029Conference ID:
13742087
Please log in approximately 10 minutes prior to
the scheduled start time. A live and archived webcast of the event
will be available on the “Investors” section of the Elutia website
at https://investors.elutia.com/.
About Elutia
Elutia develops and commercializes biologic
products to improve compatibility between medical devices and the
patients who need them. With a growing population in need of
implantable technologies, Elutia’s mission is humanizing medicine
so patients can thrive without compromise. For more information,
visit www.Elutia.com.
Investors:Matt SteinbergFINN
Partnersmatt.steinberg@finnpartners.com
Elutia (NASDAQ:ELUT)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Elutia (NASDAQ:ELUT)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024